Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
365.00    7.00 (1.96%)
Bid:
359.00
Ask:
362.00
Spread: 3.00 (0.836%)
Market Cap: £1.87b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

31 May 2022 16:50

RNS Number : 4475N
Caledonia Investments PLC
31 May 2022
 

Caledonia Investments plc

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Pursuant to the requirements of the Market Abuse Regulation, Caledonia Investments plc ("Caledonia" or the "Company") announces that on 30 May 2022 the following nil-cost options over ordinary 5p shares in Caledonia were granted to executive directors under the Caledonia Investments 2020 Performance Share Scheme (the "Performance Share Scheme") and in respect of compulsory deferral of bonus under the Caledonia Investments 2020 Deferred Bonus Plan (the "Deferred Bonus Plan"). The Company's share price used to determine the number of Performance Share Scheme awards and Deferred Bonus Plan awards was 3740p.

 

Executive Director

No. of shares over which Performance Share Scheme nil-cost options granted

No. of shares subject to Deferred Bonus Plan

J M B Cayzer-Colvin

14,699

4,666

T J Livett

16,444

5,217

M S D Masters

18,048

3,870

 

Subject to the rules of the Performance Share Scheme, nil-cost options are exercisable between three and ten years after the date of grant. Subject to the rules of the Deferred Bonus Plan, deferred share awards vest after a three year retention period.

 

The total number of awards held by the above-named executive directors of Caledonia under the Company's performance share schemes and deferred bonus plans following these nil-cost option grants are as follows:

 

Executive Director

Total no. of shares held under option under performance share scheme

Total deferred bonus plan share awards

J M B Cayzer-Colvin

91,668

14,716

T J Livett

76,483

10,173

M S D Masters

75,657

13,978

 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

Enquiries:

Mr R Webster

Company Secretary

Tel: + 44 20 7802 8080

 

31 May 2022

 

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under (1) the Caledonia Investments 2020 Performance Share Scheme ("PSS") and (2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

14,699

Grant of DBP award

 

£0.00

4,666

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

19,365

 

Nil

e)

 

Date of the transaction

 

30 May 2022

f)

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Timothy James Livett

2

 

Reason for the notification

 

a)

 

Position/status

 

Director/Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under (1) the Caledonia Investments 2020 Performance Share Scheme ("PSS") and (2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

Grant of PSS awards

 

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

16,444

Grant of DBP award

 

£0.00

5,217

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

21,661

 

Nil

e)

 

Date of the transaction

 

30 May 2022

f)

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Mathew Simon Dexter Masters

2

 

Reason for the notification

 

a)

 

Position/status

 

Director/Chief Executive Officer Designate

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under (1) the Caledonia Investments 2020 Performance Share Scheme ("PSS") and (2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

18,048

Grant of DBP award

 

£0.00

3,870

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

21,918

 

Nil

 

e)

 

Date of the transaction

 

30 May 2022

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDUCSXDGDB
Date   Source Headline
19th Aug 20247:00 amRNSCaledonia acquires Direct Tyre Management
19th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20242:30 pmRNSNet Asset Value(s)
5th Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20247:00 amRNSTotal Voting Rights
29th Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20245:31 pmRNSResult of AGM
15th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 202411:29 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.